Euroopa Liit - eesti - EMA (European Medicines Agency)

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunosupressandid - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

Euroopa Liit - eesti - EMA (European Medicines Agency)

sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - muud alimentary seedetrakti ja ainevahetust tooted, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.

Eesti - eesti - Ravimiamet

shasun pharmaceuticals limited - streptokinaas - süstelahuse pulber - 1500000rÜ 1tk

Eesti - eesti - Ravimiamet

hansa biopharma ab - imlifidaas - infusioonilahuse kontsentraadi pulber - 11mg 1viaal; 11mg 2viaal

Eesti - eesti - Ravimiamet

levim biotech llp - streptokinaas - süstelahuse pulber - 1500000tÜ 1tk